Individuals who lose weight quickly often notice increased skin laxity, hollowed cheeks, pronounced wrinkles, and a more tired or aged appearance
Retatrutide remains investigational, while FDA-approved products containing tirzepatide and semaglutide are available for specific indications
New FDA policy on compounding GLP-1 drugs New FDA policy on compounding GLP-1 drugs On April 24, 2025, FDA announced that licensed pharmacies and physicians can no longer compound semaglutide (a GLP-1 drug used in Ozempic & Wegovy) and outsourcing facilities must stop production by May 22, 2025
Peptides of Interest for Perimenopausal Women: An Evidence Review Below, I'll review the peptides most commonly discussed for women in perimenopause, along with what the research actually showsand doesn't show
To achieve the best results, it is essential to accompany its use with a nutritious diet and constant physical activity
Here is the critical detail that many people miss
.webp)
